Controlled Protein Translocation in Nanopores for Sequencing Applications
Project Number5R21GM148844-02
Contact PI/Project LeaderPETERSON, ERIC MAYO
Awardee OrganizationELECTRONIC BIOSCIENCES, INC.
Description
Abstract Text
Project Summary
The ultimate goal in the field of proteomics is single-molecule, high-accuracy, de novo protein sequencing.
Unfortunately, current proteomics technologies are costly, and lack the sensitivity, dynamic range, throughput,
scale, and accuracy needed to meet this goal. During this project, we will begin examining the technological
components and methods required to enable state-of-the-art protein sequencing and characterization. More
specifically, we will develop methods for controllably translocating a protein through a nanopore reader such that
the protein can be sequenced. Nanopore-based sequencing provides a path to characterizing both high- and
low-abundance proteins by sequencing proteins one molecule at a time, but with high accuracy, sensitivity and
throughput needed to cover the wide dynamic range in protein abundance in the proteome. During this project,
we will develop a completely new nanopore-based technology for de novo protein sequencing. We will develop
and build a novel protein sequencing system prototype, fully assess and optimize the associated
workflow/methodology for highly controlled and versatile protein/peptide characterization, and demonstrate initial
sequencing for various proteins and peptides. At the conclusion of this project, we will have successfully
demonstrated feasibility for a practical nanopore-based protein sequencing concept.
Public Health Relevance Statement
Project Narrative
This program is aimed at developing and validating the individual components and the overall methodology for
new nanopore-based technology capable of direct, de novo, single-molecule sequencing of full-length proteins.
Rapid, reliable, high-throughput, low-cost, protein sequencing and characterization will enable basic biological
research; a more comprehensive assessment of gene expression, protein variations and post translational
modifications; and faster disease biomarker discovery and validation, as well as enhanced clinical testing and
monitoring of diseases.
No Sub Projects information available for 5R21GM148844-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21GM148844-02
Patents
No Patents information available for 5R21GM148844-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21GM148844-02
Clinical Studies
No Clinical Studies information available for 5R21GM148844-02
News and More
Related News Releases
No news release information available for 5R21GM148844-02
History
No Historical information available for 5R21GM148844-02
Similar Projects
No Similar Projects information available for 5R21GM148844-02